How GLP-1s and RAGE control diabetic kidney damage
Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found...
top of page
Browse by category
Search
Levita Magnetics reveals first international deployment of MARS Surgical System
Levita Magnetics announced the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile. This marks...
Bariatric patients have lower pregnancy weight gain vs non-surgical controls
Women with a history of bariatric surgery had lower pregnancy weight gain than matched controls with similar early-pregnancy...
Factors associated with long-term use of FDA-approved anti-obesity medications
Only 19% of the patients continued to use the anti-obesity medications (AOMs) one year after their initial prescriptions and patients...
Zepbound (tirzepatide) available in US pharmacies for adults living with obesity
Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...
Journal Watch 6/12/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Comprehensive preoperative evaluations and individualised treatment plans reduced post-surgical ICU
Researchers from the King Hamad Univeristy Hospital, Muharraq, Bahrain, have reported much lower rate of intensive care unit (ICU)...
FDA approves Tonix’ Phase 2 Trial of TNX-2900 for Prader-Willi Syndrome
The FDA has cleared Tonix Pharmaceuticals’ Investigational New Drug (IND) application to support clinical development of TNX-2900...
Roche poised to enter anti-obesity medication market with agreement to acquire Carmot Therapeutics
Roche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...
Pemvidutide achieves 15.6% weight loss at 48 weeks
Topline results from the MOMENTUM Phase 2 obesity trial of pemvidutide has shown at week 48, subjects receiving pemvidutide achieved mean...
Browse by tag
bottom of page